Nane Griem-Krey
Guest Researcher
ORCID: 0000-0003-0897-6692
1 - 2 out of 2Page size: 10
- 2022
- Published
CaMKIIα as a Promising Drug Target for Ischemic Grey Matter
Griem-Krey, Nane, Clarkson, A. N. & Wellendorph, Petrine, 2022, In: Brain Sciences. 12, 12, 21 p., 1639.Research output: Contribution to journal › Review › Research › peer-review
- Published
The CaMKIIα hub ligand Ph-HTBA promotes neuroprotection after focal ischemic stroke by a distinct molecular interaction
Griem-Krey, Nane, Gauger, Stine Juul, Gowing, E. K., Thiesen, L., Frølund, Bente, Clarkson, A. N. & Wellendorph, Petrine, 2022, In: Biomedicine and Pharmacotherapy. 156, 10 p., 113895.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 203150894
Most downloads
-
150
downloads
Synthesis and Pharmacological Evaluation of [C-11]4-Methoxy-N-[2-(thiophen-2-yl) imidazo[1,2-a] pyridin-3-yl]benzamide as a Brain Penetrant PET Ligand Selective for the delta-Subunit-Containing gamma-Aminobutyric Acid Type A Receptors
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
19
downloads
The CaMKIIα hub ligand Ph-HTBA promotes neuroprotection after focal ischemic stroke by a distinct molecular interaction
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
16
downloads
CaMKIIα as a Promising Drug Target for Ischemic Grey Matter
Research output: Contribution to journal › Review › Research › peer-review
Published